These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 9325342

  • 1. Peptide mapping of the [125I]Iodoazidoketanserin and [125I]2-N-[(3'-iodo-4'-azidophenyl)propionyl]tetrabenazine binding sites for the synaptic vesicle monoamine transporter.
    Sievert MK, Ruoho AE.
    J Biol Chem; 1997 Oct 10; 272(41):26049-55. PubMed ID: 9325342
    [Abstract] [Full Text] [Related]

  • 2. High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells.
    Sievert MK, Thiriot DS, Edwards RH, Ruoho AE.
    Biochem J; 1998 Mar 01; 330 ( Pt 2)(Pt 2):959-66. PubMed ID: 9480916
    [Abstract] [Full Text] [Related]

  • 3. The photoactivatable inhibitor 7-azido-8-iodoketanserin labels the N terminus of the vesicular monoamine transporter from bovine chromaffin granules.
    Sagné C, Isambert MF, Vandekerckhove J, Henry JP, Gasnier B.
    Biochemistry; 1997 Mar 18; 36(11):3345-52. PubMed ID: 9116013
    [Abstract] [Full Text] [Related]

  • 4. Specific derivatization of the vesicle monoamine transporter with novel carrier-free radioiodinated reserpine and tetrabenazine photoaffinity labels.
    Sievert MK, Hajipour AR, Ruoho AE.
    Anal Biochem; 2007 Aug 01; 367(1):68-78. PubMed ID: 17559790
    [Abstract] [Full Text] [Related]

  • 5. Photoaffinity labeling of the monoamine transporter of bovine chromaffin granules and other monoamine storage vesicles using 7-azido-8-[125I]iodoketanserin.
    Isambert MF, Gasnier B, Laduron PM, Henry JP.
    Biochemistry; 1989 Mar 07; 28(5):2265-70. PubMed ID: 2719952
    [Abstract] [Full Text] [Related]

  • 6. Molecular pharmacology of the vesicular monoamine transporter.
    Henry JP, Sagné C, Botton D, Isambert MF, Gasnier B.
    Adv Pharmacol; 1998 Mar 07; 42():236-9. PubMed ID: 9327887
    [No Abstract] [Full Text] [Related]

  • 7. Expression cloning of a reserpine-sensitive vesicular monoamine transporter.
    Erickson JD, Eiden LE, Hoffman BJ.
    Proc Natl Acad Sci U S A; 1992 Nov 15; 89(22):10993-7. PubMed ID: 1438304
    [Abstract] [Full Text] [Related]

  • 8. Noncovalent and covalent labeling of vesicular monoamine transporter with tetrabenazine and ketanserin derivatives; purification of photolabeled protein.
    Henry JP, Sagné C, Isambert MF, Gasnier B.
    Methods Enzymol; 1998 Nov 15; 296():73-83. PubMed ID: 9779441
    [No Abstract] [Full Text] [Related]

  • 9. Amino- and amido-tetrabenazine derivatives: synthesis and evaluation as potential ligands for the vesicular monoamine transporter.
    Canney DJ, Kung MP, Kung HF.
    Nucl Med Biol; 1995 May 15; 22(4):527-35. PubMed ID: 7550031
    [Abstract] [Full Text] [Related]

  • 10. Effects of nerve growth factor on dihydrotetrabenazine binding to PC12 cells.
    Adamson CR, Emley TE, Herbig LJ, Near JA.
    Neurochem Int; 1997 May 15; 30(4-5):411-5. PubMed ID: 9106255
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.
    Lee LC, Vander Borght T, Sherman PS, Frey KA, Kilbourn MR.
    J Med Chem; 1996 Jan 05; 39(1):191-6. PubMed ID: 8568807
    [Abstract] [Full Text] [Related]

  • 12. Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.
    Teng L, Crooks PA, Dwoskin LP.
    J Neurochem; 1998 Jul 05; 71(1):258-65. PubMed ID: 9648873
    [Abstract] [Full Text] [Related]

  • 13. Identification of the serotonin-S2 receptor ligand binding site by photoaffinity labelling with 7-azido-8-[125I]ketanserin ([125I]AZIK).
    Wouters W, Van Dun J, Laduron PM.
    FEBS Lett; 1987 Mar 23; 213(2):359-64. PubMed ID: 3556587
    [Abstract] [Full Text] [Related]

  • 14. Mutagenesis and derivatization of human vesicle monoamine transporter 2 (VMAT2) cysteines identifies transporter domains involved in tetrabenazine binding and substrate transport.
    Thiriot DS, Ruoho AE.
    J Biol Chem; 2001 Jul 20; 276(29):27304-15. PubMed ID: 11375404
    [Abstract] [Full Text] [Related]

  • 15. Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.
    Kilbourn M, Lee L, Vander Borght T, Jewett D, Frey K.
    Eur J Pharmacol; 1995 May 24; 278(3):249-52. PubMed ID: 7589162
    [Abstract] [Full Text] [Related]

  • 16. Binding of [3H]dihydrotetrabenazine and [125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles.
    Cesura AM, Bertocci B, Da Prada M.
    Eur J Pharmacol; 1990 Sep 04; 186(1):95-104. PubMed ID: 2149340
    [Abstract] [Full Text] [Related]

  • 17. Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine.
    Peter D, Vu T, Edwards RH.
    J Biol Chem; 1996 Feb 09; 271(6):2979-86. PubMed ID: 8621690
    [Abstract] [Full Text] [Related]

  • 18. Characterization of high-affinity [3H]TBZOH binding to the human platelet vesicular monoamine transporter.
    Zucker M, Weizman A, Rehavi M.
    Life Sci; 2001 Sep 28; 69(19):2311-7. PubMed ID: 11669473
    [Abstract] [Full Text] [Related]

  • 19. Electrochemical monitoring of transport by a vesicular monoamine transporter expressed in Xenopus oocytes.
    Whitley J, Parsons J, Freeman J, Liu Y, Edwards RH, Near JA.
    J Neurosci Methods; 2004 Feb 15; 133(1-2):191-9. PubMed ID: 14757360
    [Abstract] [Full Text] [Related]

  • 20. Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping.
    Vaughan RA.
    Mol Pharmacol; 1995 May 15; 47(5):956-64. PubMed ID: 7746282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.